GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Effects of ghrelin on glucose-sensing and gastric distension sensitive neurons in rat dorsal vagal complex.
Wang. Wei-Guang WG; Chen. Xi X; Jiang. Hong H; Jiang. Zheng-Yao ZY
Key Findings
- Ghrelin strongly inhibits both glucose‑inhibited and glucose‑excited neurons in the dorsal vagal complex.
- Ghrelin excites gastric‑distension‑excited (GD‑EXC) neurons but suppresses gastric‑distension‑inhibited (GD‑INH) neurons.
- All these effects are blocked by a GHS‑R antagonist, confirming they are mediated through the ghrelin receptor.
Practical Outcomes
- For biohackers using GHRP‑6, raising ghrelin may blunt brain glucose‑sensing signals, which could influence blood‑sugar regulation and appetite. It may also alter stomach motility, potentially affecting digestion or feelings of fullness. The data come from anesthetized rats and don’t provide dosing guidance, so any protocol changes should be made cautiously and monitored closely.
Summary
In rats, giving ghrelin (the hormone that GHRP‑6 boosts) directly into a brain area that controls the gut and metabolism changes how certain nerve cells fire. Most of the cells that sense blood sugar get turned down, while cells that respond to stomach stretching are either turned up or down depending on their type. This shows ghrelin can tweak hunger and stomach movement signals from the brain.
Abstract
Ghrelin has been identified as the endogenous ligand of the growth hormone secretagogue receptor (GHS-R). Recent studies have shown that site-specific injection of ghrelin directly into the dorsal vagal complex (DVC) of rats is equally as sensitive in its orexigenic response to ghrelin as the arcuate nucleus of the hypothalamus (ARC). It is as yet unclear how circulating ghrelin would gain access to and influence the activity of the neurons in the DVC in which GHS receptors are expressed. In the present study, neuronal activity was recorded extracellularly in the DVC of anesthetized rats in order to examine the effects of ghrelin on the glucosensing neurons and the gastric distension (GD) sensitive neurons. The 82 neurons were tested with glucose, of which 26 were depressed by glucose and identified as glucose-inhibited (glucose-INH) neurons; 11 were activated and identified as glucose-excited (glucose-EXC) neurons. Of 26 glucose-inhibited neurons examined for response to ghrelin, 23 were depressed, 1 was activated, and 2 failed to respond to ghrelin. Nine of 11 glucose-excited neurons were suppressed by ghrelin application, and the responses are abolished by the pretreatment with the GHS-R antagonist, [D-Lys-3]-GHRP-6. In addition, of 47 DVC neurons examined for responses to gastric distension (GD), 25 were excited (GD-EXC), 18 were inhibited (GD-INH). 18 out of the 25 GD-EXC neurons were excited, whereas 15 out of 18 GD-INH neurons were suppressed by ghrelin. In conclusion, the activity of the glucosensing neurons in the DVC can be modulated by ghrelin, the primary effect of ghrelin on the glucose-INH and glucose-EXC neurons was inhibitory. Two distinct population of GD-sensitive neurons exist in the rat DVC: GD-EXC neurons are activated by ghrelin; the GD-INH neurons are suppressed by ghrelin. There is a diversity of effects of ghrelin on neuronal activity within the DVC, it is as yet unclear how this diversity in ghrelin's effects on cellular excitability contributes to ghrelin biological actions to influence food intake and gastric motility.
Study Information
pubmed
2007
2007-09-14T00:00:00.000Z
10.1016/j.regpep.2007.09.007
32
42